US Drug Recall Register
Class III · Low risk Ongoing Initiated Jul 6, 2026 (2 months ago)

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Recalling firm
Supernus Pharmaceuticals, Inc.
NDC code
17772-101-30
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0758-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Topiramate recalls

See all